Skip to content

Single-center randomized controlled trial of modified ankle pump exercise versus conventional ankle pump exercise for the prevention of lower extremity deep vein thrombosis in a healthy population

Single-center randomized controlled trial of modified ankle pump exercise versus conventional ankle pump exercise for the prevention of lower extremity deep vein thrombosis in a healthy population

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096092
Enrollment
Unknown
Registered
2025-01-17
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep vein thrombosis of the lower limbs

Interventions

Test group:Modified Ankle Pump Movement
Control group:Routine Ankle Pump Exercise

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Age 18~65 years old, gender is not limited; 2) Be conscious and fully possess the ability to perform ankle pump movements independently; 3) Those who have undergone physical examination at the health examination center of our hospital, and have a body mass index (BMI) of >24kg/m^2; 4) No anticoagulant therapy or antiplatelet therapy 1 month before the health examination in our hospital; 5) People who undergo physical examination in the health examination center of our hospital have installed exercise volume statistics applets on their smartphones or smart devices, and the daily WeChat step count is less than 5,000 steps in the first week before the physical examination; 6) Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Venous thrombosis in any part of the body confirmed by imaging before previous or physical examination; 2) Subject has a disorder of coagulation mechanism that has not been corrected, or is taking anticoagulant drugs or antiplatelet drugs for any reason; 3) Any surgery, interventional surgery or hospitalization for any reason within 1 month before the subject's health examination; 4) Have a history of cardiovascular disease other than primary lower extremity deep vein thrombosis that interferes with general physical activity, New York College of Cardiology (NYHA) cardiac function grade >=II., or have a history of chronic respiratory system requiring continuous oxygen; 5) Subject has impaired consciousness or mental illness; 6) Subject is unable to communicate normally; 7) Subject has a hematologic disease or other disease that affects coagulation function; 8) Any other conditions that the investigator considers inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Incidence of lower extremity deep vein thrombosis;

Secondary

MeasureTime frame
Lower extremity vascular resistance index;Lower extremity vasodilation end-dilation flow rate;Peak vasoconstrictive flow rate of the lower extremity;Lower extremity vascular diameter;

Countries

China

Contacts

Public ContactChunFang Hu

The First Affiliated Hospital of Army Medical University

2123996523@qq.com+86 23 68765755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026